Feature BriaCell advancing potential breakthrough immunotherapy for advanced breast cancer By Len Zehr BriaCell Therapeutics (TSXV:BCT; OTCQB:BCTXF) has reported impressive early safety and efficacy data with its lead immunotherapies for the treatment of advanced breast cancer. “Right now, there is no... May 21, 2019